Login Get Started
Browse Breadcrumb chevron Shares Breadcrumb chevron Healthcare Breadcrumb chevron Biotechnology & Medical Research Breadcrumb chevron 4Sc AG
4Sc AG logo

VSC - 4Sc AG Share News

€1.78 0.0  2.6%

Last Trade - 16/04/21

Sector
Healthcare
RiskRating
Speculative
Size
Small Cap
Style
Sucker Stock
Market Cap £78.0m
Enterprise Value £48.8m
Revenue £318k
Position in Universe 761st / 1048
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions VSC Dividends
All News
All News Reuters News Company Announcements
BRIEF-Immunic And 4SC Sign Agreement On Settlement Of Royalty Obligations For Imu-838
31st Mar News
BRIEF-4Sc Expects For 2021 Increase Of Average Monthly Use Of Cash From Operations To Between EUR 2.2 Mln - EUR 2.7 Mln
23rd Mar News
BRIEF-4SC To Issue New Shares With Expected Proceeds Of EUR 7.5 Mln
26th Nov '20 News
BRIEF-4SC Says Has Sufficient Financing Until H2 2021
20th Oct '20 News
BRIEF-4SC Announces Positive Domatinostat Pre-Clinical Data
12th Oct '20 News
BRIEF-4SC AG Announces Publication Of New Article On Domatinostat
28th Sep '20 News
BRIEF-4Sc Expands Avelumab Supply Agreement With Merck KGAA and Pfizer
15th Sep '20 News
BRIEF-4Sc And Maruho To Terminate Development Agreement Related To 4Sc's Kv1.3 Inhibitors
11th Sep '20 News
BRIEF-4SC End-H1 Cash Balance At EUR 35.2 Million
11th Aug '20 News
BRIEF-4SC Q1 Monthly Use Of Cash From Operations At EUR 1.7 Mln On Average
21st Apr '20 News
BRIEF-4Sc: FDA Accepts IND Application For MERKLIN 2 Study
8th Apr '20 News
BRIEF-4SC Expects To Continue To Report Annual Net Losses
25th Mar '20 News
BRIEF-4SC Says Data Safety Monitoring Board Recommends Continuation Of Resmain Study
31st Jan '20 News
BRIEF-4SC: First Patient Enrolled In Donimi Study
15th Jan '20 News
BRIEF-4SC Enters Avelumab Supply Agreement With Merck And Pfizer For Study Of Domatinostat In Merkel Cell Carcinoma
7th Jan '20 News
BRIEF-4SC AG: Positive Safety Review Of Phase Ib/II Emerge Study Of Domatinostat + Avelumab In Gastrointestinal Cancer
13th Dec '19 News
BRIEF-4Sc Secures About EUR 22.4 Mln From Capital Increase
12th Nov '19 News
BRIEF-4SC Provides Q3 Business Update And Outlook
17th Oct '19 News
BRIEF-4SC And Netherlands Cancer Institute Work On Evaluation Of Domatinostat
16th Oct '19 News
BRIEF-4SC Resolves To Issue New Shares
7th Oct '19 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.